`
`Newsroom Careers
`Contact Us
`
`Investor Relations
`
`Our Products
`
`Vision and Age
`
`Your Eye Concerns
`
`Our Company
`
`Home ... Rx Pharmaceutical PROLENSA (bromfenac ophthalmic solution) 0.07% CoPay Assistance
`
`PROLENSA (bromfenac ophthalmic solution) 0.07%
`
`For Eye Care
`Professionals
`
`Text size A A+
`Search...
`
` Commercially Insured/Uninsured Patients and Medicare Part D Insured Patients
`
`Each of these programs has different terms, with a minimum copay and a maximum benefit.
`
`Commercially Insured/Uninsured Patients
`Eligible patients can receive a payment assistance card, limiting their prescription
`copay cost.
`
`Medicare Part D Insured Patients
`Patients may optin to the program to pay no more than $60. For more
`information, click here.
`
`INDICATION FOR PROLENSA (bromfenac ophthalmic solution) 0.07%
`
`PROLENSA (bromfenac ophthalmic solution) 0.07% is a nonsteroidal antiinflammatory drug (NSAID) indicated to treat inflammation and reduce eye pain in
`patients after cataract surgery.
`IMPORTANT SAFETY INFORMATION ABOUT PROLENSA
`
`
`
`PROLENSA contains sodium sulfite, a substance that may cause allergic reactions, some severe, in certain people. In addition, tell your doctor if you have had an
`allergic reaction to any other medications.
`Slow or delayed healing may occur while using nonsteroidal antiinflammatory drugs (NSAIDs) such as PROLENSA.
`Use of NSAIDs in the eye may result in certain serious eye conditions that can be sight threatening. Tell your doctor immediately about any side effect that you may
`have.
`Replace bottle cap after using and do not touch dropper tip to any surface in order to avoid contamination of the bottle.
`Remove contact lenses prior to using PROLENSA. The preservative in PROLENSA, benzalkonium chloride, may be absorbed by soft contact lenses. Lenses may
`be reinserted after 10 minutes following administration of PROLENSA.
`If more than one eye medicine is being used, use the eye medicines at least 5 minutes apart.
`The most common side effects (seen in 3%8% of patients) were inflammation of the eye, foreign body sensation, eye pain, light sensitivity, and blurred vision.
`
`Please click here for Prescribing Information about PROLENSA.
`You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1800FDA1088.
`
`US/PRA/15/0042(1)
`
`Vision and Eye Health
`
`Products
`
`Customer Support
`
`Legal
`
`Vision and Age
`Eye Infections & Irritations
`Diseases and Disorders
`Find a Doctor
`Eye Exam Check List
`
`Contact Lenses
`Contact Lens Care
`Dry Eye Products
`Allergy/Redness Relief
`Rx Pharmaceutical
`Eye Vitamins
`Surgical Products
`Vision Accessories
`
`Contact Us
`Customer policies and forms
`Rebate Center
`Worldwide Locations
`
`Legal Notice
`Privacy Policy
`Safety Data Sheets (SDS)
`
`Newsroom
`Careers
`Investor Relations
`Grants & Contributions
`
`© 2016 Bausch & Lomb Incorporated.
`
`All information and materials on this site pertain to the U.S. only, unless otherwise indicated.
`
`Page 2
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
